172 related articles for article (PubMed ID: 34176289)
1. Association of HIV Infection and Antiretroviral Therapy With Arterial Stiffness: A Systematic Review and Meta-Analysis.
Kuate Defo A; Chalati MD; Labos C; Fellows LK; Mayo NE; Daskalopoulou SS
Hypertension; 2021 Aug; 78(2):320-332. PubMed ID: 34176289
[TBL] [Abstract][Full Text] [Related]
2. Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.
Msoka TF; Van Guilder GP; Smulders YM; van Furth M; Bartlett JA; van Agtmael MA
BMC Infect Dis; 2018 Dec; 18(1):708. PubMed ID: 30594160
[TBL] [Abstract][Full Text] [Related]
3. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda.
Siedner MJ; Kim JH; Nakku RS; Hemphill L; Triant VA; Haberer JE; Martin JN; Boum Y; Kwon DS; Tsai AC; Hunt PW; Okello S; Bangsberg DR
AIDS; 2016 Feb; 30(4):667-70. PubMed ID: 26636926
[TBL] [Abstract][Full Text] [Related]
5. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.
Ahamed J; Terry H; Choi ME; Laurence J
AIDS; 2016 Feb; 30(4):535-42. PubMed ID: 26605511
[TBL] [Abstract][Full Text] [Related]
7. The long-term consequences of antiretroviral therapy.
Smith D
J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
[No Abstract] [Full Text] [Related]
8. Brief Report: Vascular Dysfunction and Monocyte Activation Among Women With HIV.
Toribio M; Awadalla M; Cetlin M; Fulda ES; Stanley TL; Drobni ZD; Szczepaniak LS; Nelson MD; Jerosch-Herold M; Burdo TH; Neilan TG; Zanni MV
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):233-238. PubMed ID: 32541385
[TBL] [Abstract][Full Text] [Related]
9. [Interactions of cardiac and antiretroviral medication].
Egger S; Drewe J
Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
[TBL] [Abstract][Full Text] [Related]
10. De-"Liver"-ing HIV/hepatitis C virus-coinfected patients from antiretroviral hepatotoxicity.
Cooper CL
J Infect Dis; 2007 Sep; 196(5):656-8. PubMed ID: 17674305
[No Abstract] [Full Text] [Related]
11. Cardiovascular disease and toxicities related to HIV infection and its therapies.
Zareba KM; Miller TL; Lipshultz SE
Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
[TBL] [Abstract][Full Text] [Related]
12. Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy.
Zanetti HR; Mendes EL; Palandri Chagas AC; Gomes Douglas MO; Paranhos Lopes LT; Roever L; Gonçalves A; Santos Resende E
Curr Atheroscler Rep; 2018 May; 20(6):30. PubMed ID: 29777448
[TBL] [Abstract][Full Text] [Related]
13. Effects of HIV infection and antiretroviral therapy on the heart and vasculature.
Dubé MP; Lipshultz SE; Fichtenbaum CJ; Greenberg R; Schecter AD; Fisher SD;
Circulation; 2008 Jul; 118(2):e36-40. PubMed ID: 18566318
[No Abstract] [Full Text] [Related]
14. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
Grinspoon S; Carr A
N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
[No Abstract] [Full Text] [Related]
15. Dyslipidaemia and cardiovascular risk in HIV infection.
Kulasekaram R; Peters BS; Wierzbicki AS
Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
[TBL] [Abstract][Full Text] [Related]
16. Body shape, lipid, and cardiovascular complications of HIV therapy.
Wohl DA
Curr HIV/AIDS Rep; 2005 Jun; 2(2):74-82. PubMed ID: 16091252
[TBL] [Abstract][Full Text] [Related]
17. Limiting cardiovascular events associated with HIV and antiretroviral therapy.
Brenner BG; Baril JG
AIDS; 2017 Nov; 31(18):2551-2553. PubMed ID: 29120901
[No Abstract] [Full Text] [Related]
18. Human immunodeficiency virus and atherosclerosis.
Farrugia PM; Lucariello R; Coppola JT
Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
[TBL] [Abstract][Full Text] [Related]
19. The cardiovascular consequences of HIV and antiretroviral therapy.
Venter WD; Sanne IM
Cardiovasc J S Afr; 2003; 14(5):225-9. PubMed ID: 14610609
[TBL] [Abstract][Full Text] [Related]
20. Unstructured treatment interruption: an important risk factor for arterial stiffness in adult Malawian patients with antiretroviral treatment.
Peterson I; Ming D; Kelly C; Malisita K; Mallewa J; Mwandumba HC; Lalloo DG; Heyderman RS
AIDS; 2016 Sep; 30(15):2373-8. PubMed ID: 27428743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
